Supplementary Figure S4 from Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer
Key Points
Key points are not available for this paper at this time.
Abstract
Time on treatment among patients with long-term response (LTR).
AI에게 질문
Like
Bookmark
Share
AI에게 질문
Like
Bookmark
Share
Cite This Study
Thummalapalli et al. (Mon,) studied this question.
Supplementary Figure S4 from Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer | Synapse
Also Consider
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
2Supplementary Figure S10 from Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer2024